Short Interest & Thesis

Short Interest & Thesis — Molina Healthcare (MOH)

Reported short interest is 2.53M shares (4.93% of float, 2.7 days to cover) as of the May 29 2026 settlement — down 42% from the Nov 28 2025 peak of 4.39M shares (8.2% of float) that built through the MLR/guidance-cut shock. The bear book has been covering steadily into the +50% three-month rally, not adding; there is no public short-seller report, activist short campaign, or credible accounting allegation outstanding against MOH; and at 2.7 days-to-cover against a $175M-ADV mid-cap, the position is not crowded by any standard institutional definition. Net read for a PM: short positioning confirms the bear thesis is the mainstream MLR / Medicaid-rate one rather than something idiosyncratic, but it is not decision-useful as a thesis driver or squeeze setup.

What the tape actually says

The crash, the build, the unwind — nine months of reported positioning

The picture is unambiguous: shorts piled in around the violent Oct–Nov 2025 leg of the derating (MOH lost roughly half its market cap between the July 2025 guidance cut and the November 2025 lows), peaking at 4.39M shares / 8.2% of float on Nov 28 2025 at a price of ~$150. From that print onward the short book has been net-short-decreasing in eight of the last twelve settlement reports, falling to 2.53M / 4.93% of float by May 29 2026. A second bear push appeared in mid-February 2026 (3.77M shares at $135 on the late-January guidance disappointment) but failed to make new highs and has since unwound. The book today is below the December 2025 starting point and within ~1M shares of the pre-shock 2023 baseline.

At 4.93% of float, MOH sits well below MarketBeat's conventional "elevated" threshold (10%+) and far below any short-squeeze threshold (20%+). The 8.2% November peak was an event-driven build, not a structural crowding.

Was the +50% three-month rally just short-covering?

Over the March-31-to-May-29 rally window the short book covered ~0.92M shares — about one day of ADV, or 1.6% of total trading volume across the period. From the November 2025 peak the unwind is ~1.85M shares, ~1.1% of cumulative ADV over six months. Conclusion: mechanical short-covering is a real but minor share of the bid. The technical page's separate finding — that no recent up-day printed near 5× average volume — confirms the rally is tactical positioning + sentiment unwind, not a squeeze, but it is also not a high-confidence long-only re-entry signature.

Days-to-cover is muted because volume tripled

Days-to-cover has stayed in a 1.3–3.1 day band for the entire post-shock period — a function of trading volume tripling during the derating (annual turnover ~740% per the liquidity file). For context: pre-shock 2023 days-to-cover ran 3.4–4.8 on lower absolute shares short. MOH has become a more liquid, more actively-traded short — easier to enter, easier to exit, and structurally hard to squeeze. A clean exit of the entire 2.5M-share short book takes roughly three days at 100% of ADV or about a week at 20% participation.

Pre-shock vs post-shock baseline

The 2023 baseline was a sleepy ~3% short — almost certainly index-arb and pair-trade hedging rather than directional conviction. The 2025–2026 regime sits at roughly 2× that baseline in shares and ~1.5× in % of float, but with lower days-to-cover. The directional bet got bigger and louder; the structural ability to exit it got easier.

What the bears actually argue — there is no idiosyncratic short thesis

The single most important observation in this table is line 6. Despite a 53% drawdown from the 2025 high, a fresh law-firm investigation, and a multi-quarter earnings shock, there is no published short-seller report or activist short campaign against MOH from the major short publishers. The short book is mainstream-bear, not idiosyncratic-bear. That is consistent with the forensic-page conclusion that the FY2025 deterioration looks like a real cost-trend shock with disclosed mechanics, not a concealment pattern.

Peer context — limited but directional

The only directly-comparable disclosed peer in this run is UnitedHealth at ~1.36% of float — roughly one-quarter of MOH's level. The directional read holds even with thin data: MOH is the most-shorted name in the managed-care peer set, which is the expected outcome given (a) it is the smallest by market cap, (b) it has the highest exposure to managed Medicaid, the segment driving the current cost-trend shock, and (c) it has actually broken — peers cut guidance but did not print operating losses in Q4. The peer comparison says "this is a stressed, contrarian short" rather than "this is uniquely targeted".

Borrow pressure — no signal staged, structurally easy to borrow

No premium-style securities-lending feed is available in this run, and no public chatter surfaced flagging MOH as hard-to-borrow. The structural inference is clean — at 2.5M shares short against a 52M-share float and a $10.6B liquid mid-cap with broad institutional ownership, the borrow side is unlikely to be the constraint. If shorts were structurally squeezed by locate, the days-to-cover line would not be sitting under 3.

Implication for the investment setup

Evidence quality and limitations